By Michael Gwarisa A new high quality HIV treatment therapy and pricing regime which will accelerate availability of first affordable, generic, single-pill HIV treatment regime containing doulutegravir (DTG) will soon be launched in South Africa and Kenya before being distributed to other 90 low income countries around the world. The single-pill HIV treatment will be available to public sector purchasers in at around US$75 per person, per year. UNAIDS Executive Director Michel Sidibé said, “This agreement will improve the quality of life for millions of people living with HIV. “To…
Read More